VanEck Pharmaceutical ETF (NASDAQ:PPH) Reaches New 1-Year High at $98.15

VanEck Pharmaceutical ETF (NASDAQ:PPH)’s stock price hit a new 52-week high on Monday . The company traded as high as $98.15 and last traded at $97.95, with a volume of 28847 shares. The stock had previously closed at $98.11.

VanEck Pharmaceutical ETF Trading Down 0.2 %

The stock has a fifty day moving average price of $93.21 and a 200 day moving average price of $90.52. The firm has a market cap of $660.05 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were given a dividend of $0.3558 per share. The ex-dividend date was Monday, July 1st.

Institutional Trading of VanEck Pharmaceutical ETF

Hedge funds have recently bought and sold shares of the stock. Optimum Investment Advisors acquired a new stake in VanEck Pharmaceutical ETF during the second quarter worth $27,000. Global Retirement Partners LLC raised its stake in shares of VanEck Pharmaceutical ETF by 2,343.8% in the first quarter. Global Retirement Partners LLC now owns 391 shares of the company’s stock valued at $35,000 after acquiring an additional 375 shares during the last quarter. GPS Wealth Strategies Group LLC acquired a new position in VanEck Pharmaceutical ETF in the second quarter worth $42,000. CWM LLC acquired a new position in VanEck Pharmaceutical ETF during the 2nd quarter worth about $55,000. Finally, International Assets Investment Management LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the second quarter worth approximately $86,000.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.